Medical Tourism Market Growth, Companies Report
Nice — I pulled together a compact, citation-backed market reference for Medical Tourism: a company table (major providers / facilitator platforms with company-level revenue or relevant figures where available) plus short strategic sections (recent developments, drivers, restraints, regional split, trends, top use cases, challenges, opportunities and key expansion factors). I used recent company reports, market-research publishers and reputable news sources and cite the most important statements.
This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Medical Tourism market.
This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Medical Tourism market.
Read complete report at: https://www.thebrainyinsights.com/report/medical-tourism-market-13874
Company reference (companies + values / notes)
Notes: where a company’s full-year, company-level revenue is given I cite it; where the company reports international-patient metrics I include those instead. Numbers are the most recently reported (FY/Q) in public filings or reputable press reports.
| Company / platform | Recent company-level revenue / relevant metric (source) | How they participate in medical tourism |
|---|---|---|
| Bangkok Dusit Medical Services (BDMS) | Consolidated operating income / revenue reporting in FY24–FY25; international patients ≈ ~26–28% of patient mix / strong YoY growth in ME & Europe (BDMS MD&A & investor materials). | Thailand’s largest private hospital group — major hub for medical tourists (cardio, oncology, cosmetic, dental). |
| Bumrungrad International (Thailand) | Reported ~643,000 international medical episodes (2024); company-level notes on international patient revenue in investor reporting. | One of Asia’s most-recognised medical-tourism hospitals (JCI accredited, multi-specialty). |
| Apollo Hospitals Enterprise (India) | Consolidated healthcare services revenue ~₹55–56 billion (FY25); company publicly targeting growth in international patient contribution (MD/press). | India’s largest hospital chain — actively expanding international patient programs (South Asia, Middle East, Africa). |
| Fortis Healthcare (India) | Consolidated revenue FY25 ₹7,783 crore; international-patient revenues reported (FY25 international patient revenue ~₹539 Cr). | Major private hospital chain treating inbound international patients and regional referrals. |
| Acıbadem Healthcare Group (Turkey) | Large private Turkish operator (ranked among top EMEA groups by revenue growth; recent M&A to increase capacity). | Turkey is a major medical-tourism destination (cosmetic, dental, transplant, bariatric). |
| Grupo Empresarial Ángeles / Hospital Ángeles (Mexico) | Major Mexican private health group (market leader for Mexico medical tourism; strong outreach to US patients). | Mexico attracts US/LatAm patients for dental, bariatric, cosmetic and surgical procedures. |
| Quirónsalud (Spain, part of large European groups) | Leading Spanish private hospital group with international patient programs and European clinics. | Spain is a European hub for medical travel (orthopaedics, fertility, oncology, aesthetics). |
| Facilitator platforms (PlacidWay, MediGlobus, Bookimed, AngelesHealth, Mespoir, others) | Commercial platforms / networks connecting patients to hospitals globally; established traffic & lead funnels (PlacidWay: long-standing operator / many clinic listings). | Act as lead generators, patient coordinators, concierge and logistics managers — vital to funneling international patients. |
| Other notable hospital groups: Cleveland Clinic (international programs), Mount Elizabeth (Singapore), National University Hospital / IHH (Parkway Pantai), Apollo HealthCo partners | Large multispecialty hospital systems & Centers of Excellence that attract inbound patients and referral networks. | High-end tertiary care and centers of excellence that capture complex referrals (cardiac, oncology, transplant). |
(If you want an Excel with these companies and the exact citation links / line-item revenues side-by-side I can export that in the same turn.)
Market size & forecasts (high-level)
Selected market estimates vary by publisher:
Grand View Research: Market estimated ~USD 31.09 billion (2024) and projected to reach ~USD 87.33 billion by 2030 (CAGR ~18–19% 2025–2030).
ResearchAndMarkets / others: Example projection — USD 92.63B in 2025 and faster growth scenarios in some niche reports (CAGRs vary widely by vendor, common range ~10–20% for 2024–2029 depending on scope).
Bottom line: published market sizes differ because of methodology (what’s included — tourism + wellness + facilitation fees vs. only medical procedure spend). Use multiple vendor assumptions when modeling.
Recent developments (2023–2025)
Post-pandemic recovery of cross-border patient flows accelerated in 2023–2024, with 2024–2025 seeing strong international patient rebound in Thailand, India and Mexico (but with regional variability). Examples: BDMS and Bumrungrad reported strong international patient volumes in 2024–25.
Greater involvement of large hospital groups (BDMS, Apollo) in deliberate international-patient growth strategies and capacity expansion (beds, Centres of Excellence).
Rising scrutiny and calls for regulation in certain segments (e.g., bariatric / cosmetic surgery tourism) after adverse outcomes in some source countries.
Key drivers
Cost differentials (substantially lower prices for many procedures vs. developed-country prices).
Long wait times and capacity constraints in source markets (e.g., NHS waitlists, specialist backlogs) pushing patients overseas.
Rapid expansion of private hospital capacity and capabilities in destination countries (JCI accreditation, Centers of Excellence).
Digital lead generation & teleconsultation simplifying pre-travel diagnostics and case triage (platforms + hospital telemedicine).
Major restraints
Regulatory / medico-legal risk & continuity of care (post-op follow-up across borders remains a pain point).
Quality variability and accreditation gaps — patients need trusted accreditation and verified outcomes.
Geopolitical / travel & visa issues and short-term shocks to tourism flows (e.g., 2025 drops in visitor arrivals in some countries).
Regional segmentation (high-level)
Asia (Thailand, India, Singapore, South Korea, Turkey) — major hubs for affordability + specialist centers (Thailand and India large inbound flows; BDMS, Bumrungrad, Apollo cited).
Latin America (Mexico, Costa Rica, Colombia) — strong inbound from U.S. for dental, bariatric and elective surgeries.
Europe (Spain, Turkey) — Spain and Turkey attract Europeans and MENA patients (orthopedics, aesthetics); Turkey strong in cosmetic and hair-transplant segments.
North America — source market large (outbound patients) and also a destination for high-end care (e.g., specialty centers).
Emerging trends
Concierge / bundled recovery tourism (medical procedure + recovery + tourism packages).
Accreditation and insurer partnerships — payers and international insurers increasingly engaging with accredited providers for outbound care.
Digital triage and remote follow-up / telemedicine to improve continuity and reduce risks.
Top use cases (most common procedures)
Elective cosmetic & aesthetic surgery (including hair transplants).
Dental procedures (Mexico, Costa Rica, Eastern Europe).
Bariatric surgery and weight-loss procedures.
Cardiac, orthopaedic and oncology referral cases to centers of excellence.
Fertility / IVF services and specialized reproductive treatments.
Major challenges (industry pain points)
Post-operative care & medico-legal continuity — complications require local systems for follow-up.
Trust / transparency — patients need clear outcomes data and verified accreditation.
Data protection & cross-border health records interoperability.
Attractive opportunities
Software & platform play — teletriage, outcome registries, remote monitoring, insurer integrations (high margin, scalable).
Bundled recovery & wellness offers (recovery hotels, rehab, tourism add-ons).
Regional specialization clusters — e.g., Turkey for cosmetic and hair, Mexico for dental and bariatric, Thailand for multi-specialty hospitality.
Key factors for market expansion
Improved accreditation, outcomes transparency and insurer engagement — reduces patient risk perception.
Lower end-to-end travel friction (visas, flights, telemedicine pre-checks) — easier patient journeys increase volumes.
Continued private-hospital capacity expansion and Centres of Excellence in destination markets.
Short, actionable takeaways
If you’re building a comparable model pick 2–3 market-size sources (Grand View, ResearchAndMarkets, local country reports) and create a low/mid/high scenario — methodology and inclusions vary widely.
For competitive benchmarking, start with hospital groups that report international patient metrics (BDMS, Bumrungrad, Apollo, Grupo Ángeles, Acibadem) and facilitator platforms (PlacidWay, Bookimed, Mespoir). Use hospital investor filings for the most reliable international-patient KPIs.
Watch regulatory & post-op continuity risk (especially for bariatric/cosmetic tourism) — this can affect insurance partnerships and source-market referrals.
Would you like any of these converted into:
a one-page slide (PPT/PDF) summarizing companies + market figures, or
an Excel file listing each company with the exact source links and numeric values used (I’ll include the cited links and the vendor assumptions side-by-side)?
Tell me which file you prefer and I’ll create it now with the source links embedded. (I already gathered the source set used above.)
Comments
Post a Comment